Is Myotonic Dystrophy Type 2 Misdiagnosed as Fibromyalgia?

Yes, myotonic dystrophy type 2 (DM2) is frequently misdiagnosed as fibromyalgia ^[1][2]. Because both conditions share core symptoms like chronic, widespread muscle pain and profound fatigue ^[3][4], many patients spend years with a fibromyalgia diagnosis before receiving the correct genetic answer ^[1][5]. The early symptoms of DM2 can be mild and vague, mimicking fibromyalgia and leading to significant diagnostic delays ^[6][1].

Why Misdiagnosis Happens: Overlapping Symptoms

Both DM2 and fibromyalgia cause debilitating muscle pain and exhaustion that severely impact a person’s daily life ^[4][3]. In a doctor’s office, complaints of chronic aches and tiredness often point toward fibromyalgia, especially since it is a common diagnosis when standard blood tests come back normal ^[5].

However, researchers note that the source of the pain differs between the two conditions. Fibromyalgia is generally thought to involve central nervous system hypersensitivity, whereas pain in DM2 is often characterized by mechanical hyperalgesia—meaning the pain originates locally in the peripheral muscle tissue due to genetic and molecular changes ^[3][7][8].

How Neurologists Differentiate DM2 from Fibromyalgia

While the daily experience of pain might feel similar, neurologists look for specific clinical clues and run specialized tests to tell the two apart. Fibromyalgia is primarily a clinical diagnosis of exclusion, while DM2 is a distinct genetic disorder with objective, measurable signs ^[9][10].

• Elevated CK Blood Levels: A simple blood test can measure creatine kinase (CK), an enzyme that leaks into the bloodstream when muscle is damaged. In DM2, CK levels are often elevated ^[11]. In fibromyalgia, CK levels are typically normal. Finding high CK levels in someone with chronic muscle pain is a strong signal for doctors to investigate a muscle disease like DM2 ^[11][12].
• Electromyography (EMG): This test measures the electrical activity of muscles. During an EMG, small needles are inserted into the muscle to record its electrical signals. In people with DM2, the machine picks up a unique pattern called a myotonic discharge ^[13]. This signals myotonia, which is a delayed ability for muscles to relax after contracting. When played on the EMG machine’s speaker, these rapid electrical firings sound like a revving motorcycle or a “dive bomber” ^[13]. This distinct sound is a hallmark of myotonia and does not occur in fibromyalgia ^[13].
• Unique Physical Clues: Doctors also look for “red flags” unique to DM2 that are absent in fibromyalgia. These include grip myotonia (difficulty quickly opening your hand after gripping a doorknob), early-onset cataracts, hearing loss, and weakness in the hips and shoulders, which might feel like difficulty climbing stairs or getting up from a chair ^[14][15][10]. However, the physical signs of myotonia can be extremely subtle or unnoticeable in everyday life for DM2 patients, which is exactly why objective tests like the EMG are so important ^[13][15]. The presence of these systemic issues highlights that DM2 is a multisystem disorder rather than isolated muscle pain ^[16][17].
• Genetic Testing: The definitive way to confirm DM2 is through a genetic blood test. The test looks for an abnormal expansion (a repeated sequence) in the CNBP gene ^[10][18]. A positive genetic test confirms DM2 and differentiates it from a primary pain syndrome like fibromyalgia ^[19][5]. Because DM2 is an inherited condition, a positive test also means that your biological relatives could be at risk or currently misdiagnosed themselves ^[5].

What This Means for Your Care

Receiving a DM2 diagnosis after years of treating fibromyalgia marks an important shift in your care. Because the root cause of the pain is different, the medications and therapies you have been using for fibromyalgia may not be the most effective approach for DM2 ^[9][3]. It is crucial to work with your care team to safely review your current medications, adjust your pain management strategies, and begin monitoring for other systemic aspects of DM2, such as cardiac function ^[16].